NewAmsterdam Pharma Co N.V. - 8-K Filing
NewAmsterdam Pharma Co N.V. filed an 8-K to report shareholder approval at its June 2, 2026 annual meeting for the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan (ESPP), which allows employees to purchase up to 1,150,000 ordinary shares at a 15% discount during six-month periods. Shareholders also approved nine proposals including financial statements, auditor appointments, and board reappointments with voting results detailed in the filing. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $NAMS